Physician profile

Daphna Henkin

Internal Medicine · Olney, MD

NPI 1831160233

$3,651.65

in general payments reported to CMS, 2019-2025

35 companies · $608 in 2025

The $608 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,663.43

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $365.80 2021-2025
Novo Nordisk INC $324.72 2019-2025 Wegovy, Ozempic, Rybelsus
Astellas Pharma US INC $299.09 2019-2025 Veozah
Pfizer INC. $286.65 2020-2025
Amgen INC. $263.74 2021-2025 Evenity, Repatha, Otezla
Astrazeneca Pharmaceuticals LP $221.30 2019-2025 Breztri, Airsupra
Glaxosmithkline, LLC. $144.82 2021-2025 Trelegy Ellipta, Arexvy, Shingrix
Abbott Laboratories $143.27 2022-2025 Freestyle Libre 3
Lilly USA, LLC $142.59 2021-2025 Zepbound, Mounjaro
Merck Sharp & Dohme LLC $140.79 2019-2024 Gardasil, Gardasil 9, Capvaxive
Sanofi-Aventis U.S. LLC $136.66 2019-2022
Gilead Sciences, INC. $131.00 2021-2022
Kowa Pharmaceuticals America, INC. $130.26 2019-2022
Boehringer Ingelheim Pharmaceuticals, INC. $126.45 2019-2024 Jardiance
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $124.09 2020-2025 Xifaxan
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Exact Sciences Corporation $83.63 2023-2024 Cologuard Collection Kit
Amneal Pharmaceuticals LLC $76.79 2019-2023 Unithroid
Radius Health, INC. $71.13 2019-2024 Tymlos
Daiichi Sankyo INC. $56.29 2021-2022
Takeda Pharmaceuticals U.S.A., INC. $45.52 2021-2022
Ortho-Clinical Diagnostics, INC. $39.49 2025 Vitros
Allergan, INC. $36.57 2019-2020
Amarin Pharma, INC. $31.35 2021
Biohaven Pharmaceutical Holding Company LTD. $29.11 2022
Horizon Therapeutics Plc $28.95 2021
Eisai INC. $26.11 2020-2021
Bausch Health US, LLC $21.79 2025 Aplenzin
Myriad Women'S Health, INC. $21.52 2023 Myrisk
Quidel Corporation $19.87 2021
Dexcom, INC. $19.01 2022
Ibsa Pharma INC. $14.66 2022
Sanofi Pasteur INC. $14.41 2019
Janssen Pharmaceuticals, INC $11.96 2020
Ironwood Pharmaceuticals, INC $11.34 2020
Arbor Pharmaceuticals, INC. $10.92 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daphna Henkin

$3,651.65

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $608 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/310293/daphna-henkin

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.